- Home
- AAPG vs FULT Comparison
AAPG vs FULT Comparison
Compare AAPG & FULT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAPG
- FULT
- Stock Information
- Founded
- AAPG 2009
- FULT 1882
- Country
- AAPG China
- FULT United States
- Employees
- AAPG N/A
- FULT N/A
- Industry
- AAPG Biotechnology: Pharmaceutical Preparations
- FULT Major Banks
- Sector
- AAPG Health Care
- FULT Finance
- Exchange
- AAPG Nasdaq
- FULT Nasdaq
- Market Cap
- AAPG 3.6B
- FULT 3.2B
- IPO Year
- AAPG 2025
- FULT N/A
- Fundamental
- Price
- AAPG $40.54
- FULT $19.42
- Analyst Decision
- AAPG Buy
- FULT Hold
- Analyst Count
- AAPG 1
- FULT 3
- Target Price
- AAPG N/A
- FULT $20.67
- AVG Volume (30 Days)
- AAPG 11.7K
- FULT 1.3M
- Earning Date
- AAPG 11-06-2025
- FULT 10-14-2025
- Dividend Yield
- AAPG N/A
- FULT 3.72%
- EPS Growth
- AAPG N/A
- FULT 1.58
- EPS
- AAPG N/A
- FULT 1.71
- Revenue
- AAPG $54,524,554.00
- FULT $1,211,863,000.00
- Revenue This Year
- AAPG N/A
- FULT N/A
- Revenue Next Year
- AAPG $387.72
- FULT $7.86
- P/E Ratio
- AAPG N/A
- FULT $11.33
- Revenue Growth
- AAPG N/A
- FULT 12.50
- 52 Week Low
- AAPG $16.50
- FULT $14.33
- 52 Week High
- AAPG $48.45
- FULT $22.49
- Technical
- Relative Strength Index (RSI)
- AAPG N/A
- FULT 56.84
- Support Level
- AAPG N/A
- FULT $19.14
- Resistance Level
- AAPG N/A
- FULT $19.56
- Average True Range (ATR)
- AAPG 0.00
- FULT 0.36
- MACD
- AAPG 0.00
- FULT -0.04
- Stochastic Oscillator
- AAPG 0.00
- FULT 35.23
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.
About FULT Fulton Financial Corporation
Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.